{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:56:22Z","timestamp":1790636182264,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T00:00:00Z","timestamp":1731369600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Commun Biol"],"DOI":"10.1038\/s42003-024-06996-8","type":"journal-article","created":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T12:36:25Z","timestamp":1731414985000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Synthetic indole derivatives as an antibacterial agent inhibiting respiratory metabolism of multidrug-resistant gram-positive bacteria"],"prefix":"10.1038","volume":"7","author":[{"given":"Nishtha","family":"Chandal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Kalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Dey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rushikesh","family":"Tambat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-3688-2234","authenticated-orcid":false,"given":"Nisha","family":"Mahey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Jachak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4301-6355","authenticated-orcid":false,"given":"Hemraj","family":"Nandanwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,12]]},"reference":[{"key":"6996_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cell.2020.02.056","volume":"181","author":"K Lewis","year":"2020","unstructured":"Lewis, K. The science of antibiotic discovery. Cell 181, 29\u201345 (2020).","journal-title":"Cell"},{"key":"6996_CR2","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/S0140-6736(04)16897-9","volume":"364","author":"HF Wertheim","year":"2004","unstructured":"Wertheim, H. F. et al. Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet 364, 703\u2013705 (2004).","journal-title":"Lancet"},{"key":"6996_CR3","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1128\/IAI.00420-13","volume":"81","author":"TE Kehl-Fie","year":"2013","unstructured":"Kehl-Fie, T. E. et al. MntABC and MntH contribute to systemic Staphylococcus aureus infection by competing with calprotectin for nutrient manganese. Infect. Immun. 81, 3395\u20133405 (2013).","journal-title":"Infect. Immun."},{"key":"6996_CR4","doi-asserted-by":"publisher","unstructured":"CDC. Antibiotic Resistance Threats in the United States, 2019. Atlanta, GA:U.S. Department of Health and Human Services, CDC https:\/\/doi.org\/10.15620\/cdc:82532 (2019).","DOI":"10.15620\/cdc:82532"},{"key":"6996_CR5","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1093\/cid\/ciw828","volume":"64","author":"SB Doernberg","year":"2017","unstructured":"Doernberg, S. B. et al. Gram-positive bacterial infections: research priorities, accomplishments, and future directions of the antibacterial resistance leadership group. Clin. Infect. Dis. 64, S24\u2013S29 (2017).","journal-title":"Clin. Infect. Dis."},{"key":"6996_CR6","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1021\/acsmedchemlett.7b00501","volume":"9","author":"S Ni","year":"2018","unstructured":"Ni, S. et al. Novel staphyloxanthin inhibitors with improved potency against multidrug resistant staphylococcus aureus. ACS Med. Chem. Lett. 9, 233\u2013237 (2018).","journal-title":"ACS Med. Chem. Lett."},{"key":"6996_CR7","doi-asserted-by":"crossref","unstructured":"Chandal, N. et al. Efflux pump inhibitory potential of indole derivatives as an arsenal against norA over-expressing Staphylococcus aureus. Microbiol. Spectr. 11, e04876-04822 (2023).","DOI":"10.1128\/spectrum.04876-22"},{"key":"6996_CR8","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1089\/ars.2013.5447","volume":"20","author":"CN Paiva","year":"2014","unstructured":"Paiva, C. N. & Bozza, M. T. Are reactive oxygen species always detrimental to pathogens? Antioxid. Redox Signal. 20, 1000\u20131037 (2014).","journal-title":"Antioxid. Redox Signal."},{"key":"6996_CR9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1016\/j.bbabio.2014.03.017","volume":"1837","author":"LA Schurig-Briccio","year":"2014","unstructured":"Schurig-Briccio, L. A., Yano, T., Rubin, H. & Gennis, R. B. Characterization of the type 2 NADH:menaquinone oxidoreductases from Staphylococcus aureus and the bactericidal action of phenothiazines. Biochim. Biophys. Acta 1837, 954\u2013963 (2014).","journal-title":"Biochim. Biophys. Acta"},{"key":"6996_CR10","doi-asserted-by":"publisher","unstructured":"Mohapatra, S. S., Dwibedy, S. K. & Padhy, I. Polymyxins, the last-resort antibiotics: mode of action, resistance emergence, and potential solutions. J. Biosci. 46, https:\/\/doi.org\/10.1007\/s12038-021-00209-8 (2021).","DOI":"10.1007\/s12038-021-00209-8"},{"key":"6996_CR11","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1016\/j.cell.2020.01.021","volume":"180","author":"JM Stokes","year":"2020","unstructured":"Stokes, J. M. et al. A deep learning approach to antibiotic discovery. Cell 180, 688\u2013702.e613 (2020).","journal-title":"Cell"},{"key":"6996_CR12","doi-asserted-by":"publisher","unstructured":"Zhao, X. & Kuipers, O. P. Brevicidine B. A new member of the brevicidine family, displays an extended target specificity. Front. Microbiol. 12, https:\/\/doi.org\/10.3389\/fmicb.2021.693117 (2021).","DOI":"10.3389\/fmicb.2021.693117"},{"key":"6996_CR13","doi-asserted-by":"publisher","unstructured":"Miller, C. et al. PanG, a new ketopantoate reductase involved in pantothenate synthesis. J. Bacteriol. 195, https:\/\/doi.org\/10.1128\/JB.01740-12 (2012).","DOI":"10.1128\/JB.01740-12"},{"key":"6996_CR14","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1074\/jbc.M411608200","volume":"280","author":"R Leonardi","year":"2005","unstructured":"Leonardi, R. et al. A pantothenate kinase from staphylococcus aureus refractory to feedback regulation by coenzyme A*. J. Biol. Chem. 280, 3314\u20133322 (2005).","journal-title":"J. Biol. Chem."},{"key":"6996_CR15","doi-asserted-by":"publisher","first-page":"17067","DOI":"10.1038\/nmicrobiol.2017.67","volume":"2","author":"WK Kwong","year":"2017","unstructured":"Kwong, W. K., Zheng, H. & Moran, N. A. Convergent evolution of a modified, acetate-driven TCA cycle in bacteria. Nat. Microbiol. 2, 17067 (2017).","journal-title":"Nat. Microbiol."},{"key":"6996_CR16","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1111\/mmi.12507","volume":"91","author":"A Heikal","year":"2014","unstructured":"Heikal, A. et al. Structure of the bacterial type II NADH dehydrogenase: a monotopic membrane protein with an essential role in energy generation. Mol. Microbiol. 91, 950\u2013964 (2014).","journal-title":"Mol. Microbiol."},{"key":"6996_CR17","doi-asserted-by":"publisher","first-page":"e45832","DOI":"10.15252\/embr.201845832","volume":"21","author":"LA Schurig-Briccio","year":"2020","unstructured":"Schurig-Briccio, L. A. et al. Role of respiratory NADH oxidation in the regulation of Staphylococcus aureus virulence. EMBO Rep. 21, e45832 (2020).","journal-title":"EMBO Rep."},{"key":"6996_CR18","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1021\/acsinfecdis.2c00622","volume":"9","author":"M Saini","year":"2023","unstructured":"Saini, M. et al. Small molecule IITR00693 (2-Aminoperimidine) synergizes polymyxin B activity against staphylococcus aureus and pseudomonas aeruginosa. ACS Infect. Dis. 9, 692\u2013705 (2023).","journal-title":"ACS Infect. Dis."},{"key":"6996_CR19","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1038\/ja.2013.111","volume":"67","author":"ZZ Deris","year":"2014","unstructured":"Deris, Z. Z. et al. A secondary mode of action of polymyxins against Gram-negative bacteria involves the inhibition of NADH-quinone oxidoreductase activity. J. Antibiot. 67, 147\u2013151 (2014).","journal-title":"J. Antibiot."},{"key":"6996_CR20","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.bbabio.2018.03.014","volume":"1859","author":"J Petri","year":"2018","unstructured":"Petri, J. et al. Structure of the NDH-2 - HQNO inhibited complex provides molecular insight into quinone-binding site inhibitors. Biochim. Biophys. Acta Bioenerg. 1859, 482\u2013490 (2018).","journal-title":"Biochim. Biophys. Acta Bioenerg."},{"key":"6996_CR21","doi-asserted-by":"crossref","unstructured":"Bender, D. A. in Encyclopedia of Food Sciences and Nutrition (Second Edition) (ed Benjamin Caballero) 5851\u20135856 (Academic Press, 2003).","DOI":"10.1016\/B0-12-227055-X\/01363-8"},{"key":"6996_CR22","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.2147\/IDR.S208757","volume":"12","author":"W Yuan","year":"2019","unstructured":"Yuan, W. et al. Indole-core-based novel antibacterial agent targeting FtsZ. Infect. Drug Resist 12, 2283\u20132296 (2019).","journal-title":"Infect. Drug Resist"},{"key":"6996_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.freeradbiomed.2016.04.002","volume":"96","author":"P Korge","year":"2016","unstructured":"Korge, P., Calmettes, G. & Weiss, J. N. Reactive oxygen species production in cardiac mitochondria after complex I inhibition: modulation by substrate-dependent regulation of the NADH\/NAD(+) ratio. Free Radic. Biol. Med. 96, 22\u201333 (2016).","journal-title":"Free Radic. Biol. Med."},{"key":"6996_CR24","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1016\/j.chembiol.2013.07.006","volume":"20","author":"MayaA Farha","year":"2013","unstructured":"Farha, MayaA., Verschoor, ChrisP., Bowdish, D. & Brown, EricD. Collapsing the proton motive force to identify synergistic combinations against staphylococcus aureus. Chem. Biol. 20, 1168\u20131178 (2013).","journal-title":"Chem. Biol."},{"key":"6996_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s42770-021-00655-4","volume":"53","author":"AM El-Ganiny","year":"2022","unstructured":"El-Ganiny, A. M., Gad, A. I., El-Sayed, M. A., Shaldam, M. A. & Abbas, H. A. The promising anti-virulence activity of candesartan, domperidone, and miconazole on Staphylococcus aureus. Braz. J. Microbiol. 53, 1\u201318 (2022).","journal-title":"Braz. J. Microbiol."},{"key":"6996_CR26","doi-asserted-by":"publisher","unstructured":"Elmesseri, R. A., Saleh, S. E., Elsherif, H. M., Yahia, I. S. & Aboshanab, K. M. Staphyloxanthin as a potential novel target for deciphering promising anti-staphylococcus aureus agents. Antibiotics 11, https:\/\/doi.org\/10.3390\/antibiotics11030298 (2022).","DOI":"10.3390\/antibiotics11030298"},{"key":"6996_CR27","doi-asserted-by":"publisher","unstructured":"Subhadra, B., Kim, D. H., Woo, K., Surendran, S. & Choi, C. H. Control of biofilm formation in healthcare: recent advances exploiting quorum-sensing interference strategies and multidrug efflux pump inhibitors. Materials 11, https:\/\/doi.org\/10.3390\/ma11091676 (2018).","DOI":"10.3390\/ma11091676"},{"key":"6996_CR28","first-page":"1165","volume":"50","author":"K Kikuchi","year":"1992","unstructured":"Kikuchi, K. & Shimizu, K. Post-antibiotic effect and clinical significance. Nihon Rinsho. Jpn. J. Clin. Med. 50, 1165\u20131172 (1992).","journal-title":"Nihon Rinsho. Jpn. J. Clin. Med."},{"key":"6996_CR29","doi-asserted-by":"publisher","first-page":"224","DOI":"10.4103\/0971-6580.121674","volume":"20","author":"E Chinedu","year":"2013","unstructured":"Chinedu, E., Arome, D. & Ameh, F. S. A new method for determining acute toxicity in animal models. Toxicol. Int. 20, 224\u2013226, (2013).","journal-title":"Toxicol. Int."},{"key":"6996_CR30","first-page":"497","volume":"106","author":"E Walum","year":"1998","unstructured":"Walum, E. Acute oral toxicity. Environ. Health Perspect. 106, 497\u2013503 (1998).","journal-title":"Environ. Health Perspect."},{"key":"6996_CR31","first-page":"221","volume":"9","author":"MH Ahmed","year":"2014","unstructured":"Ahmed, M. H. et al. Methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus faecalis and Enterococcus faecium active dimeric isobutyrylphloroglucinol from Ivesia gordonii. Nat. Prod. Commun. 9, 221\u2013224 (2014).","journal-title":"Nat. Prod. Commun."},{"key":"6996_CR32","doi-asserted-by":"crossref","unstructured":"Kaplan, N. et al. Mode of action, in vitro activity, and in vivo efficacy of AFN-1252, a selective antistaphylococcal FabI inhibitor. Antimicrbial Agents and Chemotherapy 56, 5865\u20135874 (2012).","DOI":"10.1128\/AAC.01411-12"},{"key":"6996_CR33","doi-asserted-by":"publisher","first-page":"6253","DOI":"10.1016\/j.bmc.2016.05.052","volume":"24","author":"SD Taylor","year":"2016","unstructured":"Taylor, S. D. & Palmer, M. The action mechanism of daptomycin. Bioorg. Med. Chem. 24, 6253\u20136268 (2016).","journal-title":"Bioorg. Med. Chem."},{"key":"6996_CR34","doi-asserted-by":"crossref","unstructured":"Spry, C., Kirk, K. & Saliba, K. J. Coenzyme A biosynthesis: an antimicrobial drug target. FEMS Microbiol. Rev. 32, 56\u2013106 (2008).","DOI":"10.1111\/j.1574-6976.2007.00093.x"},{"key":"6996_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/srep22894","volume":"6","author":"Y Matsumoto","year":"2016","unstructured":"Matsumoto, Y. et al. A critical role of mevalonate for peptidoglycan synthesis in Staphylococcus aureus. Sci. Rep. 6, 22894 (2016).","journal-title":"Sci. Rep."},{"key":"6996_CR36","doi-asserted-by":"publisher","first-page":"e00213","DOI":"10.1128\/JCM.00213-21","volume":"59","author":"R Humphries","year":"2021","unstructured":"Humphries, R., Bobenchik, A. M., Hindler, J. A. & Schuetz, A. N. Overview of changes to the clinical and laboratory standards institute performance standards for antimicrobial susceptibility testing, M100, 31st Edition. J. Clin. Microbiol 59, e00213\u2013e00221 (2021).","journal-title":"J. Clin. Microbiol"},{"key":"6996_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nature14098","volume":"517","author":"LL Ling","year":"2015","unstructured":"Ling, L. L. et al. A new antibiotic kills pathogens without detectable resistance. Nature 517, 455\u2013459 (2015).","journal-title":"Nature"},{"key":"6996_CR38","first-page":"418","volume":"75","author":"T Bhando","year":"2019","unstructured":"Bhando, T. et al. Antibacterial properties and in vivo efficacy of a novel nitrofuran, IITR06144, against MDR pathogens. J. Antimicrob. Chemother. 75, 418\u2013428 (2019). J Journal of Antimicrobial Chemotherapy.","journal-title":"J. Antimicrob. Chemother."},{"key":"6996_CR39","doi-asserted-by":"publisher","first-page":"4210","DOI":"10.1128\/AAC.49.10.4210-4219.2005","volume":"49","author":"T Bogdanovich","year":"2005","unstructured":"Bogdanovich, T., Ednie, L. M., Shapiro, S. & Appelbaum, P. C. Antistaphylococcal activity of ceftobiprole, a new broad-spectrum cephalosporin. Antimicrob. Agents Chemother. 49, 4210\u20134219 (2005).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6996_CR40","doi-asserted-by":"publisher","first-page":"112533","DOI":"10.1016\/j.ejmech.2020.112533","volume":"205","author":"SN Sovari","year":"2020","unstructured":"Sovari, S. N. et al. Design, synthesis and in vivo evaluation of 3-arylcoumarin derivatives of rhenium(I) tricarbonyl complexes as potent antibacterial agents against methicillin-resistant Staphylococcus aureus (MRSA). Eur. J. Med. Chem. 205, 112533 (2020).","journal-title":"Eur. J. Med. Chem."},{"key":"6996_CR41","doi-asserted-by":"publisher","unstructured":"Hudson, M. A., Siegele, D. A. & Lockless, S. W. Use of a fluorescence-based assay to measure escherichia coli membrane potential changes in high throughput. Antimicrob. Agents Chemother. 64, https:\/\/doi.org\/10.1128\/aac.00910-20 (2020).","DOI":"10.1128\/aac.00910-20"},{"key":"6996_CR42","doi-asserted-by":"publisher","first-page":"7235","DOI":"10.1021\/bi9826299","volume":"38","author":"M Wu","year":"1999","unstructured":"Wu, M., Maier, E., Benz, R. & Hancock, R. E. Mechanism of interaction of different classes of cationic antimicrobial peptides with planar bilayers and with the cytoplasmic membrane of Escherichia coli. Biochemistry 38, 7235\u20137242 (1999).","journal-title":"Biochemistry"},{"key":"6996_CR43","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1128\/AAC.01217-10","volume":"55","author":"N Morin","year":"2011","unstructured":"Morin, N. et al. Mechanism of bactericidal activity of microcin L in Escherichia coli and Salmonella enterica. Antimicrob. Agents Chemother. 55, 997\u20131007 (2011).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6996_CR44","doi-asserted-by":"publisher","first-page":"6819","DOI":"10.1128\/AAC.00061-14","volume":"58","author":"M Cheng","year":"2014","unstructured":"Cheng, M., Huang, J. X., Ramu, S., Butler, M. S. & Cooper, M. A. Ramoplanin at bactericidal concentrations induces bacterial membrane depolarization in Staphylococcus aureus. Antimicrob. Agents Chemother. 58, 6819\u20136827 (2014).","journal-title":"Antimicrob. Agents Chemother."},{"key":"6996_CR45","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1021\/acsinfecdis.9b00159","volume":"6","author":"S French","year":"2020","unstructured":"French, S. et al. Potentiation of antibiotics against gram-negative bacteria by Polymyxin B analogue SPR741 from unique perturbation of the outer membrane. ACS Infect. Dis. 6, 1405\u20131412 (2020).","journal-title":"ACS Infect. Dis."},{"key":"6996_CR46","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1099\/jmm.0.047316-0","volume":"62","author":"S Leejae","year":"2013","unstructured":"Leejae, S., Hasap, L. & Voravuthikunchai, S. P. Inhibition of staphyloxanthin biosynthesis in Staphylococcus aureus by rhodomyrtone, a novel antibiotic candidate. J. Med. Microbiol. 62, 421\u2013428 (2013).","journal-title":"J. Med. Microbiol."},{"key":"6996_CR47","doi-asserted-by":"publisher","first-page":"111933","DOI":"10.1016\/j.biopha.2021.111933","volume":"141","author":"A Valliammai","year":"2021","unstructured":"Valliammai, A. et al. Staphyloxanthin inhibitory potential of thymol impairs antioxidant fitness, enhances neutrophil mediated killing and alters membrane fluidity of methicillin resistant Staphylococcus aureus. Biomed. Pharmacother. 141, 111933 (2021).","journal-title":"Biomed. Pharmacother."},{"key":"6996_CR48","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1093\/infdis\/jit173","volume":"208","author":"SY Tong","year":"2013","unstructured":"Tong, S. Y. et al. Virulence of endemic nonpigmented northern Australian Staphylococcus aureus clone (clonal complex 75, S. argenteus) is not augmented by staphyloxanthin. J. Infect. Dis. 208, 520\u2013527 (2013).","journal-title":"J. Infect. Dis."},{"key":"6996_CR49","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1084\/jem.20050846","volume":"202","author":"GY Liu","year":"2005","unstructured":"Liu, G. Y. et al. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity. J. Exp. Med. 202, 209\u2013215 (2005).","journal-title":"J. Exp. Med."},{"key":"6996_CR50","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s42003-020-01530-y","volume":"4","author":"MAT Blaskovich","year":"2021","unstructured":"Blaskovich, M. A. T. et al. The antimicrobial potential of cannabidiol. Commun. Biol. 4, 7 (2021).","journal-title":"Commun. Biol."},{"key":"6996_CR51","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s11274-013-1326-0","volume":"29","author":"EA Trafny","year":"2013","unstructured":"Trafny, E. A., Lewandowski, R., Zawistowska-Marciniak, I. & St\u0119pi\u0144ska, M. Use of MTT assay for determination of the biofilm formation capacity of microorganisms in metalworking fluids. World J. Microbiol. Biotechnol. 29, 1635\u20131643 (2013).","journal-title":"World J. Microbiol. Biotechnol."},{"key":"6996_CR52","first-page":"794","volume":"55","author":"M Levin-Arama","year":"2016","unstructured":"Levin-Arama, M. et al. Subcutaneous compared with intraperitoneal KetamineXylazine for anesthesia of mice. J. Am. Assoc. Lab. Anim. Sci. 55, 794\u2013800 (2016).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"6996_CR53","doi-asserted-by":"crossref","unstructured":"Gao, P. et al. Antivirulence Agent as an Adjuvant of \u03b2-Lactam Antibiotics in Treating Staphylococcal Infections. Antibiotics (Basel, Switzerland). 11, 819 (2022).","DOI":"10.3390\/antibiotics11060819"}],"container-title":["Communications Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06996-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06996-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06996-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,12]],"date-time":"2024-11-12T14:07:29Z","timestamp":1731420449000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s42003-024-06996-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,12]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["6996"],"URL":"https:\/\/doi.org\/10.1038\/s42003-024-06996-8","relation":{},"ISSN":["2399-3642"],"issn-type":[{"value":"2399-3642","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,12]]},"assertion":[{"value":"12 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was carried out in compliance with the recommendations of the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA). The protocol (IAEC\/21\/05) was approved by the Institute of Microbial Technology\u2019s Institutional Animal Ethics Committee in Chandigarh, India. We have complied with all relevant ethical regulations for animal use. We have used female, BALB\/c mice of 5\u20137 weeks in our experiments. Randomization and blinding were not regarded as necessary for infection animal models. During the histopathology investigation, the observer was unaware of the control and treatment groups.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"1489"}}